Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH

B Bedi, JY Li, H Tawfeek, KH Baek… - Proceedings of the …, 2012 - National Acad Sciences
B Bedi, JY Li, H Tawfeek, KH Baek, J Adams, SS Vangara, MK Chang, M Kneissel…
Proceedings of the National Academy of Sciences, 2012National Acad Sciences
Intermittent parathyroid hormone (iPTH) treatment stimulates T-cell production of the
osteogenic Wnt ligand Wnt10b, a factor required for iPTH to activate Wnt signaling in
osteoblasts and stimulate bone formation. However, it is unknown whether iPTH induces
Wnt10b production and bone anabolism through direct activation of the parathyroid
hormone (PTH)/PTH-related protein receptor (PPR) in T cells. Here, we show that
conditional silencing of PPR in T cells blunts the capacity of iPTH to induce T-cell production …
Intermittent parathyroid hormone (iPTH) treatment stimulates T-cell production of the osteogenic Wnt ligand Wnt10b, a factor required for iPTH to activate Wnt signaling in osteoblasts and stimulate bone formation. However, it is unknown whether iPTH induces Wnt10b production and bone anabolism through direct activation of the parathyroid hormone (PTH)/PTH-related protein receptor (PPR) in T cells. Here, we show that conditional silencing of PPR in T cells blunts the capacity of iPTH to induce T-cell production of Wnt10b; activate Wnt signaling in osteoblasts; expand the osteoblastic pool; and increase bone turnover, bone mineral density, and trabecular bone volume. These findings demonstrate that direct PPR signaling in T cells plays an important role in PTH-induced bone anabolism by promoting T-cell production of Wnt10b and suggest that T cells may provide pharmacological targets for bone anabolism.
National Acad Sciences